On March 24, 2025, Shenzhen Medical Academy of Research and Translation (SMART), Shenzhen Bay Laboratory(SZBL), and Nanchang University formalized a strategic cooperation framework agreement at Nanchang University. This collaboration aims to deepen integration in biomedical research, accelerate scientific innovation and translational outcomes, and inject new momentum into high-quality development in life sciences and healthcare.
Nieng Yan, President of SMART and Director of SZBL, and Yeguang Chen, President of Nanchang University, delivered keynote speeches. Huan Tu, Vice President of SMART and Deputy Director of SZBL, and Shaoping Nie, Vice President of Nanchang University, signed the agreement on behalf of the three institutions.
Joint Research Initiatives
Overcome chokepoint technologies in biomedicine through cutting-edge research, including structural biology, drug development, and disease mechanisms.
Talent Development
Establish a joint doctoral training program and strengthen high-level faculty exchanges and interdisciplinary education.
Resource Sharing
Share large-scale scientific instruments, experimental platforms, and clinical data to enhance research efficiency.
Translational Medicine
Build an integrated innovation chain spanning "basic research–clinical translation–industrial application" to accelerate commercialization of breakthroughs.
Nieng Yan emphasized leveraging SMART and SZBL’s strengths in foundational research alongside Nanchang University’s clinical resources. She highlighted the partnership as a model for "clinical demand-driven research," accelerating the transformation of scientific discoveries into real-world solutions.
During discussions with Sihai Luo, Secretary of the Party Committee of Nanchang University, Nieng Yan underscored the importance of cross-regional synergy and building an innovation ecosystem that integrates industry, academia, research, and medical applications.
This agreement aligns with China’s national strategy to achieve scientific self-reliance and advance biomedical innovation. By combining resources and expertise, the partnership aims to tackle key biomedical technologies and contribute to the Guangdong-Hong Kong-Macao Greater Bay Area’s vision of becoming a global hub for science and industrial innovation.
